tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

AMLX Stock Latest News

Amylyx price target raised to $30 from $25 at Guggenheim
The FlyAmylyx price target raised to $30 from $25 at Guggenheim
3d ago
AMLX
Buy Rating on Amylyx Pharmaceuticals Driven by Avexitide’s Commercial Potential and De-Risked Phase III PBH Program
PremiumRatings
Buy Rating on Amylyx Pharmaceuticals Driven by Avexitide’s Commercial Potential and De-Risked Phase III PBH Program
6d ago
AMLX
Amylyx Pharmaceuticals Maps High-Stakes Path to 2027
PremiumCompany Announcements
Amylyx Pharmaceuticals Maps High-Stakes Path to 2027
11d ago
AMLX
Amylyx price target raised to $34 from $28 at H.C. Wainwright
PremiumThe Fly
Amylyx price target raised to $34 from $28 at H.C. Wainwright
18d ago
AMLX
Amylyx Pharmaceuticals: Solid Balance Sheet, Advancing Pipeline, and Attractive Risk‑Reward Support Buy Rating
PremiumRatings
Amylyx Pharmaceuticals: Solid Balance Sheet, Advancing Pipeline, and Attractive Risk‑Reward Support Buy Rating
19d ago
AMLX
Amylyx files automatic mixed securities shelf
PremiumThe FlyAmylyx files automatic mixed securities shelf
19d ago
AMLX
Amylyx reports Q4 EPS (30c), consensus (34c)
Premium
The Fly
Amylyx reports Q4 EPS (30c), consensus (34c)
19d ago
AMLX
Amylyx initiated with a Buy at Stifel
Premium
The Fly
Amylyx initiated with a Buy at Stifel
19d ago
AMLX
Is AMLX a Buy, Before Earnings?
PremiumPre-Earnings
Is AMLX a Buy, Before Earnings?
21d ago
AMLX
Amylyx price target raised to $19 from $15 at BofA
PremiumThe Fly
Amylyx price target raised to $19 from $15 at BofA
30d ago
AMLX
Amylyx price target raised to $19 from $18 at Mizuho
PremiumThe Fly
Amylyx price target raised to $19 from $18 at Mizuho
1M ago
AMLX
Amylyx price target raised to $19 from $18 at Mizuho
PremiumThe Fly
Amylyx price target raised to $19 from $18 at Mizuho
1M ago
AMLX
Amylyx price target raised to $28 from $20 at H.C. Wainwright
PremiumThe FlyAmylyx price target raised to $28 from $20 at H.C. Wainwright
1M ago
AMLX
Buy Rating on Amylyx: Avexitide’s High Unmet Need, Strong PBH Opportunity, and Clear Phase III Catalyst Support Upside
Premium
Ratings
Buy Rating on Amylyx: Avexitide’s High Unmet Need, Strong PBH Opportunity, and Clear Phase III Catalyst Support Upside
2M ago
AMLX
Amylyx Advances AMX0318 as New Rare-Disease Candidate
Premium
Company Announcements
Amylyx Advances AMX0318 as New Rare-Disease Candidate
2M ago
8K
AMLX
Amylyx selects AMX0318 as development candidate for PBH
PremiumThe Fly
Amylyx selects AMX0318 as development candidate for PBH
2M ago
AMLX
Amylyx price target lowered to $15 from $16 at BofA
PremiumThe Fly
Amylyx price target lowered to $15 from $16 at BofA
3M ago
AMLX
Positive Buy Rating for Amylyx Pharmaceuticals Based on Promising Phase I LUMINA Study Results and Strategic Advancements
PremiumRatings
Positive Buy Rating for Amylyx Pharmaceuticals Based on Promising Phase I LUMINA Study Results and Strategic Advancements
4M ago
AMLX
Amylyx price target raised to $18 from $16 at Mizuho
PremiumThe Fly
Amylyx price target raised to $18 from $16 at Mizuho
4M ago
AMLX
Amylyx price target raised to $20 from $16 at H.C. Wainwright
PremiumThe FlyAmylyx price target raised to $20 from $16 at H.C. Wainwright
4M ago
AMLX
Amylyx Pharmaceuticals Reports Strong Q3 2025 Results
Premium
Company Announcements
Amylyx Pharmaceuticals Reports Strong Q3 2025 Results
5M ago
AMLX
Amylyx Pharmaceuticals: Positive Earnings Call Highlights Progress and Challenges
Premium
Company Announcements
Amylyx Pharmaceuticals: Positive Earnings Call Highlights Progress and Challenges
5M ago
AMLX

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >